225 related articles for article (PubMed ID: 12057046)
21. [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].
Gligorov J; André T; Epaud C; Culine S
Bull Cancer; 2002 Aug; 89 Spec No():S134-44. PubMed ID: 12449045
[TBL] [Abstract][Full Text] [Related]
22. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Bunn PA
Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine and paclitaxel in metastatic breast cancer: a review.
Colomer R
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):8-12. PubMed ID: 15685819
[TBL] [Abstract][Full Text] [Related]
24. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.
Le Chevalier T
Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960
[TBL] [Abstract][Full Text] [Related]
25. Gemcitabine/anthracycline combinations in metastatic breast cancer.
Zielinski CC
Clin Breast Cancer; 2002 May; 3 Suppl 1():30-3. PubMed ID: 12057043
[TBL] [Abstract][Full Text] [Related]
26. Advanced breast cancer: investigational role of gemcitabine.
Carmichael J; Walling J
Eur J Cancer; 1997 Jan; 33 Suppl 1():S27-30. PubMed ID: 9166097
[TBL] [Abstract][Full Text] [Related]
27. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine and targeted therapy in metastatic breast cancer.
Qu G; Perez EA
Semin Oncol; 2002 Jun; 29(3 Suppl 11):44-52. PubMed ID: 12138397
[TBL] [Abstract][Full Text] [Related]
29. Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.
Zielinski CC
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):36-40. PubMed ID: 14768404
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
Sanal SM; Gokmen E; Karabulut B; Sezgin C
Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine in non-small cell lung cancer.
Crinò L; Cappuzzo F
Expert Opin Pharmacother; 2002 Jun; 3(6):745-53. PubMed ID: 12036414
[TBL] [Abstract][Full Text] [Related]
32. Development of gemcitabine in non-small cell lung cancer: the Italian contribution.
Metro G; Cappuzzo F; Finocchiaro G; Toschi L; Crinò L
Ann Oncol; 2006 May; 17 Suppl 5():v37-46. PubMed ID: 16807461
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiation in NSCLC: focus on the role of gemcitabine.
Choy H
Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):38-42. PubMed ID: 15339058
[TBL] [Abstract][Full Text] [Related]
34. The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer.
Ngeow J; Toh CK
Curr Drug Targets; 2010 Jan; 11(1):61-6. PubMed ID: 19839926
[TBL] [Abstract][Full Text] [Related]
35. Gemcitabine and taxanes as a new standard of care in breast cancer.
Yardley DA
Clin Breast Cancer; 2004 Jan; 4 Suppl 3():S107-12. PubMed ID: 14754467
[TBL] [Abstract][Full Text] [Related]
36. Clinical studies of pemetrexed and gemcitabine combinations.
Adjei AA
Ann Oncol; 2006 May; 17 Suppl 5():v29-32. PubMed ID: 16807459
[TBL] [Abstract][Full Text] [Related]
37. The pemetrexed/gemcitabine combination in pancreatic cancer.
Kindler HL
Cancer; 2002 Aug; 95(4 Suppl):928-32. PubMed ID: 12209673
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials.
Bria E; Milella M; Gelibter A; Cuppone F; Pino MS; Ruggeri EM; Carlini P; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
Cancer; 2007 Aug; 110(3):525-33. PubMed ID: 17577216
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
Hansen HH; Sørensen JB
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
[TBL] [Abstract][Full Text] [Related]
40. The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation.
Takeda AL; Jones J; Loveman E; Tan SC; Clegg AJ
Health Technol Assess; 2007 May; 11(19):iii, ix-xi, 1-62. PubMed ID: 17462169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
